Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol

Details for Australian Patent Application No. 2002221689 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Stephenne, Jean; Gerard, Catherine Marie Ghislaine; Garcon, Nathalie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002221689

PCT Pub. Number WO02/32454

Priority 0025577.8 18.10.00 GB

Filing date 16 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 1 April 2004

International Classifications

A61K 039/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 031/335 - having oxygen as the only ring hetero atom, e.g. fungichromin

Event Publications

1 April 2004 Application Accepted

  Published as AU-B-2002221689

29 July 2004 Standard Patent Sealed

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221690

2002221688